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Intraoperative Parathyroid Hormone Measurement vs
Indocyanine Green Angiography of Parathyroid Glands
in Prediction of Early Postthyroidectomy Hypocalcemia
The identification of predictors of postoperative hypocalce-
mia in thyroid surgery is a focus of interest. Perioperative mea-
surement of parathyroid hormone (PTH) levels and angiogra-
phy of the parathyroids with indocyanine green (ICG) have been
explored, with different conclusions.1-5 In this study, we com-
pared the diagnostic accuracy of intraoperative measure-
ment of intact PTH (ioPTH) levels and parathyroid gland
angiography with ICG to predict early hypocalcemia in a co-
hort of patients in whom at least 4 glands were identified.
Methods | The study was approved by the institutional review
board of Hospital Universitari de Bellvitge, and all patients gave
written informed consent. Patients undergoing total thyroid-
ectomy with or without central neck dissection between May
2016 and October 2018 were included in a prospective co-
hort. Inclusion criteria were identification of 4 parathyroid
glands intraoperatively or if the sum of in situ glands plus
autotransplanted glands plus those in the histopathologic
report was at least 4. Previous thyroid-parathyroid surgery and
treatment with calcium were exclusion criteria. Intraopera-
tive angiography after thyroidectomy was performed as pre-
viously described.3 The degree of ICG fluorescence on para-
thyroids was classified as 0, black (nonvascularized); 1, gray/
heterogeneous (partially vascularized); and 2, white (well
vascularized). The ioPTH levels were measured preopera-
tively and 10 minutes after completion of thyroid surgery using
a chemiluminescent immunometric assay (reference, 17.1-
74.2 pg/mL; to convert to nanograms per liter, multiply by 1).5
The percentage of PTH decline was calculated as (preopera-
tive PTH−postresection PTH)/preoperative PTH × 100. Crite-
ria for predicting hypocalcemia were a decrease in ioPTH level
of at least 62.5% or less than 17.1 pg/mL. The serum calcium
Table 1. Distribution of Patients According to Predictors of Early Postoperative Hypocalcemia
Variable
No. (%)
P Value
All Patients
(N = 50)
Postoperative Hypocalcemia
Absent (n = 39) Present (n = 11)
ioPTH level, pg/mL, mean (SD)
Baseline (preoperative) 52.4 (2.0) 51.4 (2.1) 56.2 (1.8) .45a
Final (10 min after thyroidectomy) 25.7 (1.5) 25.5 (1.4) 11.4 (0.6) <.001a
ioPTH-based hypocalcemia criteria
No decrease in ioPTH level ≥62.5% 30 (60) 30 (100) 0 <.001b
Decrease in ioPTH level ≥62.5% 20 (40) 9 (45) 11 (55) NA
No final ioPTH <17.1 pg/mL 33 (66) 31 (93.9) 2 (6.1) <.001b
Final ioPTH <17.1 pg/mL 17 (34) 8 (47.1) 9 (52.9) NA
Neither criteria 34 (70) 33 (94.3) 2 (5.7) <.001b
Both criteria 15 (30) 6 (40) 9 (60)
ICG score 2, No. of glands
0 11 (22) 2 (18.2) 9 (81.8)
<.001b
1 16 (32) 15 (93.8) 1 (6.2)
2 15 (30) 14 (93.3) 1 (6.7)
3 5 (10) 5 (100) 0
4 3 (6) 3 (100) 0
ICG score 2, any gland
Present 39 (78) 37 (94.9) 2 (5.1)
<.001b
Absent 11 (22) 2 (18.2) 9 (81.8)
Surgeon’s evaluation of functioning glands
0 26 (52) 17 (65.4) 9 (34.6)
.16b
1 8 (16) 6 (75) 2 (25)
2 7 (14) 7 (100) 0
3 7 (14) 7 (100) 0
4 2 (4) 2 (100) 0
Surgeon’s evaluation
Functioning glands 24 (48) 22 (91.7) 2 (8.3)
.04b
Nonfunctioning glands 26 (52) 17 (65.4) 9 (34.6)
Abbreviations: ICG, indocyanine
green; ioPTH, intraoperative
measurement of intact parathyroid
hormone; NA, not applicable.
SI conversion factor: To convert
parathyroid hormone levels to
nanograms per liter, multiply by 1.
a t Test.
b Fisher exact test.
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level was measured using a colorimetric assay (reference, 8.60-
10.00 mg/dL [to convert to millimoles per liter, multiply by
0.25]). Also, the surgeon scored the macroscopic appearance
of the parathyroid glands as 0, nonfunctioning gland; 1, un-
certain; and 2, functioning gland, always before ICG. The
primary end point was the need for calcium supplementa-
tion. Criteria for the administration of calcium were the pres-
ence of symptoms of hypocalcemia or calcium levels less than
7.20 mg/dL in asymptomatic patients.
Results | Fifty patients (33 women [66%]) with a mean (SD) age
of 52 (12.9) years diagnosed as having thyroid cancer (n = 35
[70%]), multinodular goiter (n = 13 [26%]), and Graves disease
(n = 2 [4%]) underwent total thyroidectomy, associated with
central neck dissection in 30. Calcium supplements were needed
by 11 patients (22%) postoperatively. Differences in baseline data
between patients with and without hypocalcemia were not
found. Results of ioPTH levels, ICG angiography, and sur-
geon’s evaluation of glands viability are shown in Table 1. Of the
39 patients (78%) who did not require calcium supplementa-
tion, ioPTH correctly identified 32 of them (64%) and ICG cor-
rectly identified 37 (74%). As shown in Table 2, the diagnostic
accuracy of ICG angiography and ioPTH was similar.
Discussion | Prevention of the parathyroid function during thy-
roidectomy is clinically relevant owing to serious adverse ef-
fects of permanent hypoparathyroidism. Reported studies of
PTH levels measured at different times during or after thy-
roidectomy have shown controversial results.1,2 Indocyanine
green angiography has been proposed as a useful technique
for evaluation of the viability status of the glands, with en-
couraging results. However, the first reported studies3,4 failed
to identify all parathyroid gland tissue, and therefore, these
missing glands could be responsible for a positive outcome.
On the contrary, here we identified all parathyroid glands. In
our study, the diagnostic accuracy of ICG angiography and
ioPTH were similar to predict hypocalcemia, but this may be
a type II error, and a larger sample size would find that ICG
angiography could be superior to ioPTH. With all the parathy-
roid tissue identified, it seems that visualization of at least 1
well-perfused gland on ICG angiography is highly suggestive
of normocalcemia in the immediate postoperative period. Also,
ICG angiography would allow immediate decision-making
without the need of waiting for ioPTH measurement, al-
though a learning curve to score gland vascularization is
needed. Limitations of the study include the nonrandomized
design and the relatively small study sample.
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Characterization of High Mortality Probability
Operations at National Surgical Quality
Improvement Program Hospitals
The decision to operate on high-risk patients can be challeng-
ing. To our knowledge, there is little evidence available for guid-
ance and wide variability in practice.1 Surgeons may encoun-
ter clinical scenarios in which they believe that the chances of
Table 2. Diagnostic Accuracy of ioPTH Measurement, ICG Angiography, and Surgeon’s Macroscopic Assessment
for Predicting Early Postoperative Hypocalcemiaa
Measures
Rate (95% CI)
ioPTH ICG Score 2 Surgeon’s Assessment
Sensitivity 0.818 (0.482-0.977) 0.818 (0.482-0.977) 0.818 (0.482-0.977)
Specificity 0.846 (0.695-0.941) 0.949 (0.827-0.994) 0.564 (0.396-0.722)
Diagnostic accuracy 0.840 (0.709-0.928) 0.920 (0.808-0.978) 0.620 (0.472-0.753)
Predictive value
Positive 0.600 (0.323-0.837) 0.818 (0.482-0.977) 0.346 (0.172-0.557)
Negative 0.943 (0.808-0.993) 0.949 (0.827-0.994) 0.917 (0.730-0.990)
Abbreviations: ICG, indocyanine
green; ioPTH, intraoperative
measurement of intact parathyroid
hormone.
SI conversion factor: To convert
parathyroid hormone levels to
nanograms per liter, multiply by 1.
a Positive tests for postoperative
hypocalcemia: ioPTH decline
of at least 62.5% and less than
17.1 pg/mL; ICG no gland scored
as 2 (well vascularized).
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